QC
RDY icon

Quadrature Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Quadrature Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
+180,329
New +$2.43M 0.02% 432
2026
Q1 		– Sell
-17,010
Closed -$239K – 1768
2025
Q4 		$239K Buy
+17,010
New +$239K ﹤0.01% 922
2021
Q1 		– Sell
-63,555
Closed -$907K – 1107
2020
Q4 		$907K Buy
+63,555
New +$856K 0.04% 334

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Quadrature Capital's RDY Position: Q2 2026 in Review

Quadrature Capital opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 180,329 shares worth $2.61M. The stake represents 0.02% of the portfolio and ranks #432 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in RDY as recently as Q4 2025.

Quadrature Capital first reported a position in RDY in Q4 2020 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Quadrature Capital held 180,329 shares of Dr. Reddy's Laboratories worth $2.61M as of Q2 2026.
  • Dr. Reddy's Laboratories was a new Quadrature Capital position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #432 holding.
  • Quadrature Capital first reported a position in Dr. Reddy's Laboratories in Q4 2020 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.